Shelter Pharma IPO Listing: SME IPO makes a weak debut; shares list with 4.8% discount at ₹39.97 apiece on BSE SMEPersonal FinanceShelter Pharma IPO Listing: SME IPO makes a weak debut; shares list with 4.8% discount at ₹39.97 apiece on BSE SME

Shelter Pharma IPO Listing: SME IPO makes a weak debut; shares list with 4.8% discount at ₹39.97 apiece on BSE SME


Shelter Pharma IPO Listing: Shelter Pharma shares made a weak debut on the stock exchange Wednesday. Shelter Pharma shares were listed at 39.97 apiece on BSE SME. The listing price was at a discount of 4.83% to the issue price of 42. 

Shelter Pharma is a Gujarat-based small- and medium-sized enterprise (SME) company and is engaged in the business of manufacturing herbal products in Human Pharma as well as the Veterinary space.

Also Read: TVS Supply Chain Solutions makes a muted debut; shares list with 5% premium at 207.05 apiece on NSE

Shelter Pharma IPO, which was opened from August 10 to August 14, was subscribed 15.25 times in total as the SME IPO received bids for 5.23 crore equity shares against 36.24 lakh shares on offer.

The issue received positive response from retail investors who’s portion was subscribed 22.28 times, and non-institutional investors’ portion was subscribed 6.59 times.

Shelter Pharma IPO was a fresh issue comprising 3,816,000 equity shares of the face value of 10 aggregating up to 16.03 crore.

The SME IPO was a fixed price issue and the company issued shares at 42 apiece to the investors in the IPO.

Mustaqim Nisarahmed Sabugar and Shakil Nisarahmed Sabugar are the promoters of Shelter Pharma.

Catch Live Market Updates here

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Finplay.
Download Finplay News App to get Daily Market Updates.

More
Less

Updated: 23 Aug 2023, 10:21 AM IST

Disclaimer: Along with publishing our own news, we get news from various sources namely from news wires ANI, PTI, other reputed finance portals and individual journalists. We are not legally liable for any inaccuracies in the news and expect the reader to do their own due diligence.

http://ganesh@finplay.in

Finance enthusiast, Mutual fund expert.




Leave a Reply

Your email address will not be published. Required fields are marked *

Finplay

AMFI-registered Mutual Fund Distributor ARN-192179

Company

© 2024 Finplay Technologies Private Limited. All Rights Reserved.